ARTV Earnings Artiva Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q1 2026 | 2026-03-31 | -0.95 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -3.43 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -2.59 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.71 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.83 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -5.81 | 2026-03-10 | 10-K |
| Q3 2025 | 2024-09-30 | -7.16 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -39.24 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -17.24 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -35.78 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -20.89 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -35.12 | 2024-08-29 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.